If not us, then who? If not now, then when?
-John Lewis
Our primary goal is to address significant drawbacks in the current treatment approach, particularly in terms of effectiveness and safety. We are diligently working on an innovative portfolio that aims to make the full benefits of CAR-T cell therapy and immune cytokines more accessible to patients with hematological malignancies, solid cancers, and autoimmune diseases.
Science
Our team and advisors possess extensive scientific expertise that underpins the excellence of our CAR design and CAR-T manufacturing processes. We believe that a better CAR drives life further.
ESG is what we do
At Caarlogic Biomed, we firmly believe that a robust and efficient board of directors is essential for ensuring excellent corporate governance. We strictly adhere to environmental, social, and governance (ESG) regulations.
Financial info
Ernst & Young provides audit services for our company's financial reports.
-Statements (財報)
Shareholder service
our team
Leadership
羅浚晅 醫師
Chun-Hsuan Lo, MD.
董事長 Chairman
林建廷 醫師
Chien-Ting Lin, MD.
執行長 Chief Executive Officer
吳尚儒 醫師/博士
Shang-Ju Wu MD., PhD.
科學顧問 Scientific advisor
黃傳翔 醫師/博士
Chuan-Hsiang Bear Huang, MD., PhD.
科學顧問 Scientific advisor
林子平 醫師/博士
Tzu-Ping Lin, MD., PhD.
科學顧問 Scientific advisor
廖俊厚 醫師
Chun-Hou Liao MD.,PhD.
科學顧問 Scientific advisor
We Are Hiring
Welcome to Caarlogic Biomed's career page, where empowerment drives innovation and fosters diversity.
Internship
Caarlogic Biomed may offer short-term internship opportunities to undergraduate and graduate students during the summer.
Partners
